20+ Year Treas Bond Ishares ETF (NQ: TLT )
138.91
USD
+0.27
(+0.19%)
Official Closing Price
Updated: 7:59 PM EST, Mar 5, 2021
Add to My Watchlist
Press releases about 20+ Year Treas Bond Ishares ETF
Theralase Announces Completion of Public Offering of Units
November 10, 2016
From Marketwired
Theralase Announces Proposed Public Offering of Units
November 07, 2016
From Marketwired
Theralase Provides Update on 2016 Strategic Initiatives
March 18, 2016
From ACCESSWIRE
BlackRock’s iShares to Ring The Nasdaq Stock Market Closing Bell
February 26, 2016
The Nasdaq Stock Market® Kicks Off the New Year With Strong ETP Momentum
February 08, 2016
BlackRock Announces Changes to Four iShares Treasury ETFs
January 28, 2016
Theralase Debuts Next Generation Therapeutic Laser in US
January 13, 2016
From ACCESSWIRE
Theralase to Present at Noble Investor Conference
January 12, 2016
From ACCESSWIRE
Theralase to Present at AlphaNorth Capital Conference
January 11, 2016
From ACCESSWIRE
University Health Network Review Ethics Board Approves Clinical Study for Anti-Cancer Drug
December 28, 2015
From ACCESSWIRE
Health Canada Approves Clinical Trial Application for Anti-Cancer Drug
December 16, 2015
From ACCESSWIRE
Theralase Launches Next Generation Therapeutic Laser in Canada
December 14, 2015
From ACCESSWIRE
Health Canada Approves Next Generation TLC-2000 Therapeutic Laser
December 13, 2015
From ACCESSWIRE
Theralase Releases 3Q 2015 Financials
November 26, 2015
From ACCESSWIRE
Theralase Launches Next Generation Therapeutic Laser in USA
November 25, 2015
From ACCESSWIRE
FDA Grants Approval for Next Generation Therapeutic Laser
November 24, 2015
From ACCESSWIRE
From ACCESSWIRE
Theralase Partners with University of Ulm
November 11, 2015
From ACCESSWIRE
From ACCESSWIRE
From ACCESSWIRE
Theralase Releases AGM Presentation Videos
October 08, 2015
From ACCESSWIRE
Theralase Completes GMP Manufacture of Second Batch of Lead Drug
October 01, 2015
From ACCESSWIRE
From ACCESSWIRE
Theralase Submits Investigational Testing Authorization to Health Canada for Approval
September 18, 2015
From ACCESSWIRE
Theralase Submits Clinical Trial Application to Health Canada for Approval
September 17, 2015
From ACCESSWIRE
Theralase Completes Detailed Information on the TLC-3000B Laser System
September 15, 2015
From ACCESSWIRE
Theralase Completes Clinical Protocol
September 11, 2015
From ACCESSWIRE
Theralase Successfully Completes GLP Toxicology Analysis of Lead Drug
September 10, 2015
From ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.